Given emerging roles of dysregulated lipid metabolism in cancer growth and metastasis [31, 32], blocking FABP4 activity represents a novel strategy for breast cancer treatment as it blocks lipid transportation and metabolism, thus inhibiting cancer cell growth and metastasis. Here, FABP4 is linked to breast carcinoma.